JAGSNPHARM.NSJAGSNPHARM.NS
LOADING
|||
Operating Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$435.49M
↑ 163% above average
Average (9y)
$165.68M
Historical baseline
Range
High:$435.49M
Low:$-111.27M
CAGR
+30.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $435.49M | +103.5% |
| 2024 | $214.04M | -37.7% |
| 2023 | $343.30M | +39.9% |
| 2022 | $245.45M | +30.7% |
| 2021 | $187.86M | +153.8% |
| 2020 | $74.03M | -11.0% |
| 2019 | $83.19M | +174.8% |
| 2018 | $-111.27M | -177.3% |
| 2017 | $143.97M | +253.3% |
| 2016 | $40.75M | - |